The largest database of trusted experimental protocols

Easysep b cell negative selection kits

Manufactured by STEMCELL

The EasySep B cell negative selection kits are laboratory products designed to isolate untouched, highly purified B cells from a variety of sample types, such as peripheral blood, cord blood, and bone marrow. The kits use a fast and easy-to-use negative selection approach to enrich for B cells without directly labeling them.

Automatically generated - may contain errors

2 protocols using easysep b cell negative selection kits

1

Isolation and Stimulation of T cells and APCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD8+ polyclonal or OT-I T cells were isolated from lymph nodes of 6–8-week-old mice using EasySep CD8 negative selection kits (STEMCELL Technologies). B cells were isolated from spleens of 6–8-week-old mice using EasySep B cell negative selection kits (STEMCELL Technologies). In specified experiments, B cells were treated with 1 μg/ml LPS (Sigma-Aldrich) for 5 h before use. BMDCs were generated from treating cultured bone marrow cells with GM-CSF (granulocyte-macrophage colony-stimulating factor) for 7–11 days. IL-4 was added for the last 2 days with 1 μg/ml LPS stimulation 6–24 h before use. BMDCs and B cells were incubated with 1–100 ng/ml SL8 OVA peptide (SIINFEKL) (Anaspec), or variant peptides N4, T4, Q4H7, V4 (gift from E. Palmer and D. Zehn) for at least 30 min at 37°C and washed 3 times.
+ Open protocol
+ Expand
2

Isolation and Stimulation of T cells and APCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD8+ polyclonal or OT-I T cells were isolated from lymph nodes of 6–8-week-old mice using EasySep CD8 negative selection kits (STEMCELL Technologies). B cells were isolated from spleens of 6–8-week-old mice using EasySep B cell negative selection kits (STEMCELL Technologies). In specified experiments, B cells were treated with 1 μg/ml LPS (Sigma-Aldrich) for 5 h before use. BMDCs were generated from treating cultured bone marrow cells with GM-CSF (granulocyte-macrophage colony-stimulating factor) for 7–11 days. IL-4 was added for the last 2 days with 1 μg/ml LPS stimulation 6–24 h before use. BMDCs and B cells were incubated with 1–100 ng/ml SL8 OVA peptide (SIINFEKL) (Anaspec), or variant peptides N4, T4, Q4H7, V4 (gift from E. Palmer and D. Zehn) for at least 30 min at 37°C and washed 3 times.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!